Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.
Dalakas MC, Rakocevic G, Schmidt J, Salajegheh M, McElroy B, Harris-Love MO, Shrader JA, Levy EW, Dambrosia J, Kampen RL, et al. Brain. 2009 Jun; 132(Pt 6):1536-44. Epub 2009 May 19.